151 related articles for article (PubMed ID: 19680781)
1. Comparison of genotypes between environmental and clinical isolates of Cryptococcus neoformans var. grubii based on microsatellite patterns.
Zhu J; Kang Y; Uno J; Taguchi H; Liu Y; Ohata M; Tanaka R; Moretti ML; Mikami Y
Mycopathologia; 2010 Jan; 169(1):47-55. PubMed ID: 19680781
[TBL] [Abstract][Full Text] [Related]
2. Genotypic diversity in clinical and environmental isolates of Cryptococcus neoformans from India using multilocus microsatellite and multilocus sequence typing.
Prakash A; Sundar G; Sharma B; Hagen F; Meis JF; Chowdhary A
Mycoses; 2020 Mar; 63(3):284-293. PubMed ID: 31820495
[TBL] [Abstract][Full Text] [Related]
3. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
Chowdhary A; Randhawa HS; Sundar G; Kathuria S; Prakash A; Khan Z; Sun S; Xu J
J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452
[TBL] [Abstract][Full Text] [Related]
4. Multilocus microsatellite typing for Cryptococcus neoformans var. grubii.
Hanafy A; Kaocharoen S; Jover-Botella A; Katsu M; Iida S; Kogure T; Gonoi T; Mikami Y; Meyer W
Med Mycol; 2008 Nov; 46(7):685-96. PubMed ID: 18608927
[TBL] [Abstract][Full Text] [Related]
5. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.
Souza LK; Souza Junior AH; Costa CR; Faganello J; Vainstein MH; Chagas AL; Souza AC; Silva MR
Mycoses; 2010 Jan; 53(1):62-7. PubMed ID: 19500261
[TBL] [Abstract][Full Text] [Related]
6. Microsatellite typing of clinical and environmental Cryptococcus neoformans var. grubii isolates from Cuba shows multiple genetic lineages.
Illnait-Zaragozi MT; Martínez-Machín GF; Fernández-Andreu CM; Boekhout T; Meis JF; Klaassen CH
PLoS One; 2010 Feb; 5(2):e9124. PubMed ID: 20161737
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization and antifungal susceptibility testing of Cryptococcus neoformans sensu stricto from southern Brazil.
Herkert PF; Meis JF; Lucca de Oliveira Salvador G; Rodrigues Gomes R; Aparecida Vicente V; Dominguez Muro M; Lameira Pinheiro R; Lopes Colombo A; Vargas Schwarzbold A; Sakuma de Oliveira C; Simão Ferreira M; Queiroz-Telles F; Hagen F
J Med Microbiol; 2018 Apr; 67(4):560-569. PubMed ID: 29461182
[TBL] [Abstract][Full Text] [Related]
8. Predominance of Cryptococcus neoformans var. grubii multilocus sequence type 5 and emergence of isolates with non-wild-type minimum inhibitory concentrations to fluconazole: a multi-centre study in China.
Fan X; Xiao M; Chen S; Kong F; Dou HT; Wang H; Xiao YL; Kang M; Sun ZY; Hu ZD; Wan Z; Chen SL; Liao K; Chu YZ; Hu TS; Zou GL; Hou X; Zhang L; Zhao YP; Xu YC; Liu ZY
Clin Microbiol Infect; 2016 Oct; 22(10):887.e1-887.e9. PubMed ID: 27432767
[TBL] [Abstract][Full Text] [Related]
9. Human cryptococcosis: relationship of environmental and clinical strains of Cryptococcus neoformans var. neoformans from urban and rural areas.
Delgado AC; Taguchi H; Mikami Y; Myiajy M; Villares MC; Moretti ML
Mycopathologia; 2005 Jan; 159(1):7-11. PubMed ID: 15750727
[TBL] [Abstract][Full Text] [Related]
10. Genotypic diversity and antifungal susceptibility of environmental isolates of Cryptococcus neoformans from the Yangtze River Delta region of East China.
Chen M; Wang Y; Li Y; Hong N; Zhu X; Pan W; Liao W; Xu J; Du J; Chen J
Med Mycol; 2021 Jul; 59(7):653-663. PubMed ID: 33269400
[TBL] [Abstract][Full Text] [Related]
11. Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017.
Selb R; Fuchs V; Graf B; Hamprecht A; Hogardt M; Sedlacek L; Schwarz R; Idelevich EA; Becker SL; Held J; Küpper-Tetzel CP; McCormick-Smith I; Heckmann D; Gerkrath J; Han CO; Wilmes D; Rickerts V
Int J Med Microbiol; 2019 Sep; 309(6):151336. PubMed ID: 31444102
[TBL] [Abstract][Full Text] [Related]
12. Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility.
Liaw SJ; Wu HC; Hsueh PR
Clin Microbiol Infect; 2010 Jun; 16(6):696-703. PubMed ID: 19694765
[TBL] [Abstract][Full Text] [Related]
13. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil.
Grizante Barião PH; Tonani L; Cocio TA; Martinez R; Nascimento É; von Zeska Kress MR
Mycoses; 2020 Dec; 63(12):1341-1351. PubMed ID: 32869413
[TBL] [Abstract][Full Text] [Related]
14. MLST-Based Population Genetic Analysis in a Global Context Reveals Clonality amongst Cryptococcus neoformans var. grubii VNI Isolates from HIV Patients in Southeastern Brazil.
Ferreira-Paim K; Andrade-Silva L; Fonseca FM; Ferreira TB; Mora DJ; Andrade-Silva J; Khan A; Dao A; Reis EC; Almeida MT; Maltos A; Junior VR; Trilles L; Rickerts V; Chindamporn A; Sykes JE; Cogliati M; Nielsen K; Boekhout T; Fisher M; Kwon-Chung J; Engelthaler DM; Lazéra M; Meyer W; Silva-Vergara ML
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005223. PubMed ID: 28099434
[TBL] [Abstract][Full Text] [Related]
15. Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India.
Gutch RS; Nawange SR; Singh SM; Yadu R; Tiwari A; Gumasta R; Kavishwar A
Braz J Microbiol; 2015; 46(4):1125-33. PubMed ID: 26691471
[TBL] [Abstract][Full Text] [Related]
16. Environmental strains of Cryptococcus neoformans variety grubii in the city of Santos, SP, Brazil.
Soares MC; Paula CR; Dias AL; Caseiro MM; Costa SO
Rev Inst Med Trop Sao Paulo; 2005; 47(1):31-6. PubMed ID: 15729472
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization and antifungal susceptibility of Cryptococcus neoformans strains collected from a single institution in Lima, Peru.
Bejar V; Tello M; García R; Guevara JM; Gonzales S; Vergaray G; Valencia E; Abanto E; Ortega-Loayza AG; Hagen F; Gutierrez EL
Rev Iberoam Micol; 2015; 32(2):88-92. PubMed ID: 25556051
[TBL] [Abstract][Full Text] [Related]
18. Genotyping and antifungal susceptibility testing of Cryptococcus neoformans isolates from Cameroonian HIV-positive adult patients.
Bertout S; Drakulovski P; Kouanfack C; Krasteva D; Ngouana T; Dunyach-Rémy C; Dongtsa J; Aghokeng A; Delaporte E; Koulla-Shiro S; Reynes J; Mallié M
Clin Microbiol Infect; 2013 Aug; 19(8):763-9. PubMed ID: 23033854
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Cryptococcus neoformans isolated from urban environmental sources in Goiânia, Goiás State, Brazil.
Kobayashi CC; Souza LK; Fernandes Ode F; Brito SC; Silva AC; Sousa ED; Silva Mdo R
Rev Inst Med Trop Sao Paulo; 2005; 47(4):203-7. PubMed ID: 16138201
[TBL] [Abstract][Full Text] [Related]
20. DNA fingerprinting pattern and susceptibility to antifungal drugs in Cryptococcus neoformans variety grubii isolates from Barcelona city and rural environmental samples.
Morera-López Y; Torres-Rodríguez JM; Jiménez-Cabello T; Baró-Tomás T; Alía-Aponte C; Lázera MS
Mycopathologia; 2005 Aug; 160(1):9-14. PubMed ID: 16160762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
